Complicating autoimmune diseases in myasthenia gravis: a review

Aliona Nacu1, Jintana Bunpan Andersen, Vitalie Lisnic

  • 1a Department of Neurology , Haukeland University Hospital , Bergen , Norway .

Autoimmunity
|April 28, 2015
PubMed

Insights

Myasthenia gravis (MG) patients often have other autoimmune diseases, impacting treatment and outcomes. Recognizing these comorbidities is crucial for accurate diagnosis and management of MG.

Area of Science:

  • Neurology
  • Immunology
  • Autoimmune Diseases

Background:

  • Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions.
  • Comorbidities in MG are often overlooked but significantly influence patient outcomes.
  • MG patients exhibit a higher prevalence of other autoimmune conditions.

Purpose of the Study:

  • To review concomitant autoimmune disorders associated with different MG subgroups.
  • To analyze the impact of these comorbidities on MG treatment and prognosis.
  • To emphasize the importance of considering MG in patients with other autoimmune diseases.

Main Methods:

  • Literature review of studies on MG and associated autoimmune diseases.
  • Analysis of comorbidity data across various MG subgroups.
  • Synthesis of information on diagnostic and therapeutic implications.

Main Results:

  • Specific MG subgroups are linked to distinct patterns of autoimmune comorbidities.
  • Presence of comorbidities affects treatment strategies and patient prognosis.
  • Autoimmune thyroid disease, lupus erythematosus, and rheumatoid arthritis are common co-occurring conditions.

Conclusions:

  • Concomitant autoimmune disorders are frequent in MG and require careful consideration.
  • MG should be suspected in autoimmune patients presenting with neuromuscular symptoms.
  • Integrated management approaches are necessary for patients with coexisting autoimmune conditions.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.8K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.3K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.4K